Automatic CRT-D RESONATE™ HF

triple-chamber

Innovative technology, powerful insights. Comprehensive, novel technology in our RESONATE CRT-Ds helps physicians to identify heart failure early, restore chronotrophic competence, and improve CRT response in most patients. And they are fueled by the longest-lasting battery technology available, substantially reducing major complications and costs associated with battery replacement.1 In addition, comprehensive shock features to prevent sudden cardiac death are available today and for the future. Product Details Identify heart failure decompensation, increase CRT response, reduce costs, and improve quality of life in heart failure patients with our RESONATE family of implantable CRT-Ds (cardiac resynchronization therapy defibrillators). Boston Scientific devices are unique by providing 8 shocks in the VF zone, the option to choose shock polarity, and automatically invert shock polarity in a series of shocks HeartLogic™ Heart Failure Diagnostic can predict heart failure events weeks in advance with minimal alerts2 SmartCRT™ Technology provides customized programming to obtain CRT response in most patients3 EnduraLife™ Battery Technology extends device longevity (up to 13.2 years even with MultiSite Pacing turned on)* RightRate™ Minute Ventilation is the only sensor clinically proven to restore chronotropic competence4 (available only in RESONATE HF)